Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Rhythm Pharmaceuticals
RYTM
$6.81B
| $2.89M | ﹤0.01% |
289,106
+22,744
| +9% | +$255K |
|
2577
Oportun Financial
OPRT
$255M
| $2.88M | ﹤0.01% |
142,284
+6,654
| +5% | +$156K |
|
|
ENFN
2578
DELISTED
Enfusion, Inc.
ENFN
| $2.88M | ﹤0.01% |
+137,497
| New | +$2.78M |
|
|
DCPH
2579
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.88M | ﹤0.01% |
294,300
+8,670
| +3% | +$163K |
|
2580
Lifestance Health
LFST
$4B
| $2.87M | ﹤0.01% |
301,432
+26,360
| +10% | +$280K |
|
2581
Aspen Aerogels
ASPN
$384M
| $2.87M | ﹤0.01% |
57,622
+1,296
| +2% | +$68.3K |
|
2582
ESS Tech
GWH
$22M
| $2.85M | ﹤0.01% |
+16,630
| New | +$3.67M |
|
2583
Palladyne AI
PDYN
$247M
| $2.85M | ﹤0.01% |
+47,524
| New | +$2.16M |
|
|
BHR
2584
Braemar Hotels & Resorts
BHR
$156M
| $2.83M | ﹤0.01% |
554,737
+29,773
| +6% | +$146K |
|
|
HYZN
2585
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $2.82M | ﹤0.01% |
8,693
+113
| +1% | +$36.8K |
|
|
RDUS
2586
DELISTED
Radius Health, Inc.
RDUS
| $2.82M | ﹤0.01% |
407,615
+32,458
| +9% | +$476K |
|
2587
Talos Energy
TALO
$2.53B
| $2.81M | ﹤0.01% |
287,102
+6,645
| +2% | +$75.8K |
|
2588
Omeros
OMER
$857M
| $2.81M | ﹤0.01% |
436,368
+6,380
| +1% | +$46.3K |
|
2589
Precigen
PGEN
$2.24B
| $2.8M | ﹤0.01% |
753,705
+15,361
| +2% | +$66.1K |
|
2590
CS Disco
LAW
$250M
| $2.8M | ﹤0.01% |
78,195
-7,815
| -9% | -$347K |
|
2591
Omega Flex
OFLX
$297M
| $2.8M | ﹤0.01% |
22,019
+437
| +2% | +$58.1K |
|
2592
908 Devices
MASS
$329M
| $2.78M | ﹤0.01% |
107,353
+13,667
| +15% | +$402K |
|
2593
Axogen
AXGN
$2.27B
| $2.76M | ﹤0.01% |
294,796
+15,183
| +5% | +$182K |
|
2594
Custom Truck One Source
CTOS
$2.31B
| $2.75M | ﹤0.01% |
343,927
+4,640
| +1% | +$40K |
|
2595
OptimizeRx
OPRX
$114M
| $2.74M | ﹤0.01% |
44,070
+713
| +2% | +$54K |
|
2596
Ooma
OOMA
$598M
| $2.74M | ﹤0.01% |
133,892
-7,690
| -5% | -$157K |
|
2597
Forestar Group
FOR
$1.44B
| $2.73M | ﹤0.01% |
125,533
+1,674
| +1% | +$34.5K |
|
2598
GeneDx Holdings
WGS
$1.93B
| $2.72M | ﹤0.01% |
18,508
+226
| +1% | +$50.5K |
|
2599
Metropolitan Bank Holding Corp
MCB
$1.15B
| $2.7M | ﹤0.01% |
25,372
+4,849
| +24% | +$461K |
|
|
KLRS
2600
Kalaris Therapeutics
KLRS
$83.5M
| $2.7M | ﹤0.01% |
9,062
+186
| +2% | +$86.3K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.